Avammune Therapeutics Secures $12 Million in Series A Funding
Avammune Therapeutics secures $12 million in Series A financing to accelerate its proprietary pipeline.
Read moreDetailsAvammune Therapeutics secures $12 million in Series A financing to accelerate its proprietary pipeline.
Read moreDetailsResearch-backed Indian startup journalism. Funding rounds, mergers and acquisitions, AI, and technology — every figure checked against primary sources.
© 2026 StartupSuperb. Research-backed Indian startup news: funding, AI, and technology.
© 2026 StartupSuperb. Research-backed Indian startup news: funding, AI, and technology.